Aesculus Bio ApS: Financial statements 2021
CVR: 40560866
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Aesculus Bio ApS (CVR 40560866) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 87,677 and a net result of DKK 73,545 compared with DKK -14,631 the year before. Equity in the 2021 report amounted to DKK 166,610. The solvency ratio was 40.8%.
- Gross Profit
- DKK 87,677
- Profit/Loss
- DKK 73,545
- Equity
- DKK 166,610
- Total Assets
- DKK 408,036
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 88 t. | 74 t. | 167 t. | - |
| 2020 | - | -12 t. | -15 t. | 93 t. | - |
Official annual report
Find more companies like Aesculus Bio ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Aesculus Bio ApS has published its annual report for 2020. Gross profit came to DKK -11,740, and the net result was DKK -14,631.
About Aesculus Bio ApS
Aesculus Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Benjamin Anderschou Holbech Jensen. The board consists of Peter Hviid Nordkild (chair) and Benjamin Anderschou Holbech Jensen. The company is owned by Benjamin Anderschou Holbech Jensen, PN INVESTMENT ApS and Jan Wehkamp. In 2025, the company reported a gross profit of DKK -154,862 and a net result of DKK -129,437 compared with DKK -45,866 the year before. Equity in the 2025 report amounted to DKK -34,097.